- Home
- STIM vs SRV Comparison
STIM vs SRV Comparison
Compare STIM & SRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- SRV
- Stock Information
- Founded
- STIM 2003
- SRV 2007
- Country
- STIM United States
- SRV United States
- Employees
- STIM N/A
- SRV N/A
- Industry
- STIM Medical/Dental Instruments
- SRV Finance Companies
- Sector
- STIM Health Care
- SRV Finance
- Exchange
- STIM Nasdaq
- SRV Nasdaq
- Market Cap
- STIM 224.8M
- SRV 203.4M
- IPO Year
- STIM 2018
- SRV N/A
- Fundamental
- Price
- STIM $2.90
- SRV $44.39
- Analyst Decision
- STIM Strong Buy
- SRV
- Analyst Count
- STIM 2
- SRV 0
- Target Price
- STIM $7.00
- SRV N/A
- AVG Volume (30 Days)
- STIM 1.2M
- SRV 33.9K
- Earning Date
- STIM 11-11-2025
- SRV 01-01-0001
- Dividend Yield
- STIM N/A
- SRV 13.38%
- EPS Growth
- STIM N/A
- SRV N/A
- EPS
- STIM N/A
- SRV N/A
- Revenue
- STIM $111,106,000.00
- SRV N/A
- Revenue This Year
- STIM $105.70
- SRV N/A
- Revenue Next Year
- STIM $11.77
- SRV N/A
- P/E Ratio
- STIM N/A
- SRV N/A
- Revenue Growth
- STIM 54.17
- SRV N/A
- 52 Week Low
- STIM $0.52
- SRV $30.73
- 52 Week High
- STIM $5.92
- SRV $44.30
- Technical
- Relative Strength Index (RSI)
- STIM 47.33
- SRV 47.14
- Support Level
- STIM $2.58
- SRV $44.91
- Resistance Level
- STIM $3.01
- SRV $45.84
- Average True Range (ATR)
- STIM 0.18
- SRV 0.78
- MACD
- STIM 0.04
- SRV -0.11
- Stochastic Oscillator
- STIM 78.16
- SRV 14.66
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About SRV NXG Cushing Midstream Energy Fund of Beneficial Interest
NXG Cushing Midstream Energy Fund is a non-diversified, closed-end management investment company with an investment objective of seeking a high after-tax total return from a combination of capital appreciation and current income. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in midstream energy investments.